COMMUNIQUÉS West-GlobeNewswire

Neuralstem Appoints Ken Carter, Ph.D., as Executive Chairman of the Board
18/12/2018
- Seasoned biotech executive and accomplished scientific leader with broad experience from early-stage company development to managing publicly traded entities - GERMANTOWN, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- [...]
Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211
18/12/2018
THE WOODLANDS, Texas, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced positive topline results from its Phase 1a study of LX9211, a potent oral small molecule inhibitor of [...]
Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing
18/12/2018
Both parties to have commercialization rights REHOVOT, Israel & CAMBÉ, Brazil, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life [...]
Transactions in relation to share buyback program
18/12/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone
18/12/2018
PHOENIX, Dec. 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
Oncology Venture receives positive feed-back from the FDA on approval pathway for LiPlaCis and DRP in the US
18/12/2018
Company News Oncology Venture receives positive feed-back from the FDA on approval pathway for LiPlaCis and DRP in the US Hørsholm, Denmark and Cambridge, MA, US, December 18, 2018 – Oncology Venture A/S (“OV” or the [...]
TLC Announces Phase I/II Full Enrollment in Hernia Repair Surgery and Phase II Initiation in Bunionectomy of TLC590 for Postsurgical Pain
18/12/2018
TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development [...]
Teleradiology Innovator, DocPanel, Selects TeraRecon for Advanced Visualization and Artificial Intelligence Technologies
18/12/2018
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Teleradiology provider, DocPanel, has selected advanced visualization and artificial intelligence (AI) leader, TeraRecon, to provide subspecialty image review and processing [...]
Correction in the headline of press release in Latvian : Olainfarm Group Sales in November Grew By 8%
18/12/2018
Corrected headline of the press release in Latvian. English version remains unchanged. Preliminary consolidated results of JSC Olainfarm for November 2018 show that total sales of the Group have reached 10.9 million [...]
Herantis Pharma Plc's financial reporting schedule and annual general meeting in 2019
18/12/2018
Herantis Pharma Plc's financial reporting schedule and annual general meeting in 2019 Herantis Pharma Plc. Company release 18 December 2018 at 9:00 am Herantis Pharma Plc ("Herantis") will publish its Financial [...]
Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
18/12/2018
Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform Collaboration leverages Ares Genetics’ antibiotic resistance database ARESdb Short-term focus on repurposing existing antibiotics [...]
Rule 2.9 Announcement
18/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 December 2018 [...]
Idorsia's P2Y12 receptor antagonist - selatogrel - Phase 2 clinical studies meet their objective
18/12/2018
Allschwil, Switzerland - December 18, 2018 Idorsia Ltd (SIX: IDIA) today announced that Phase 2 clinical studies with selatogrel (recommended INN for ACT-246475), Idorsia's P2Y12 receptor antagonist, in patients with [...]
Align Technology Reaches 6 Millionth Invisalign® Patient Milestone With Tween Patient From China
18/12/2018
12-year old Yuzhe Wang from Beijing, China is in treatment with Invisalign trained doctor Jiawei Wo using Invisalign Comprehensive with Mandibular Advancement Accelerating adoption of Invisalign clear aligner treatment [...]
Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services
18/12/2018
Services and Capacity Increase with New Site Opening SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance [...]
Medexus annonce la nomination d’un nouveau chef de la direction, d’un nouveau président du conseil d’administration, d’autres mises à jour organisationnelles et des attributions d’actions incitatives
18/12/2018
MONTRÉAL, 17 déc. 2018 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (anciennement Pediapharm Inc.) (la « société ») (TSXV : PDP, OTCQB : PDDPF) a annoncé aujourd’hui des changements organisationnels visant à [...]
FibroGen Announces Approval of Roxadustat in China for the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis
18/12/2018
China is the first country to approve roxadustat First-in-class roxadustat offers a new, effective oral treatment SAN FRANCISCO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) today announced that [...]
Nemaura Medical Announces Proposed Public Offering
17/12/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]
Flexion Therapeutics Submits Supplemental New Drug Application (sNDA) for ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
17/12/2018
sNDA aims to revise the product label with new data indicating repeat administration of ZILRETTA was safe and well tolerated BURLINGTON, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) [...]

Pages